SCHEMBL7247804

SCHEMBL7247804

CCS(=O)(=O)N(OC(=O)/C=C\C(=O)OC(C)S(=O)(=O)Nc1cc(F)cc2c1OCCC2c1c[nH]cn1)c1cc(F)cc2c1OCCC2c1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7102533 0.82
SCHEMBL7098100 0.78 ADRA2A (0.38)
Fumaric Acid SCHEMBL7247808 0.76 ADRA2A (0.31)
Maleic Acid SCHEMBL7247796 0.76 ADRA2A (0.31)
SCHEMBL7103106 0.75
SCHEMBL7097676 0.75 ADRA2A (0.34)
Maleic Acid SCHEMBL7102529 0.74 TRPV1 (0.32)
Fumaric Acid SCHEMBL7102536 0.74 TRPV1 (0.32)
SCHEMBL7103690 0.73 BRAF (0.33)
SCHEMBL7103321 0.67 ADRA2A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503935-B1 Treating urinary incontinence or retrograde ejaculation ABBOTT LABORATORIES 2003-01-07 US disclosed